We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd

News   Jun 25, 2012

 
Compugen and Merck Serono Ventures to Jointly Establish New Biomarker Company Neviah Genomics Ltd
 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Computational Models of the Human Lung: Potential for Personalized Medicine & Inhalation Toxicology

News

Combining high-performance computing, high-fidelity modeling, and high-resolution medical imaging, produces simulations that have the potential to contribute to new diagnostic tools and treatment options for respiratory disease.

READ MORE

Better Tailored Drugs with Fewer Side-Effects

News

A recent achievement in the field of protein research allows for better tailored pharmaceuticals with fewer side-effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE